![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- ACOG. 2001. Practice bulletin 27. Prenatal diagnosis of fetal chromosomal abnormalities. Washington DC: American College of Obstetricians and Gynecologists.
- Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. 2000. Maternal age and fetal loss: population based register linkage study. British Medical Journal (Clinical Research edn.) 320:1708–1712.
- Bombard AT, Powers JF, Carter S, Schwartz A, Nitowsky HM. 1995. Procedure related fetal losses in transplacental versus non transplacental genetic amniocentesis. American Journal of Obstetrics and Gynecology 172:868–872.
- CEMAT Group. 1998. Canadian Early and Midtrimester Amniocentesis Trial (CEMAT) group. Randomized trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 351:242–247.
- Caughey AB, Hopkins LM, Norton ME. 2006. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstetrics and Gynecology 108:612–616.
- Eddlemann KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y . 2006. Pregnancy loss rates after midtrimester amniocentesis. Obstetrics and Gynecology 108:1067–1072.
- Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB. 1995. Increased maternal age and the risk of fetal death. New England Journal of Medicine 333:953–957.
- Giorlandino C, Mobili L, Bilancioni E, D'Alessio P, Carcioppolo O, Gentili P . 1994 Transplacental amniocentesis: it is really a high risk procedure? Prenatal Diagnosis 14:803–806.
- Hoesli IM, Walter-Gobel I, Tercanli S, Holzgreve W. 2001. Spontaneous fetal loss rates in a non selected population. American Journal of Medical Genetics 100:106–110.
- Marthin T, Liedgren S, Hammar M. 1997. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstetricia et Gynecologica Scandinavica 76:728–732.
- Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY . 2006. Risk factors for procedure related fetal losses after midtrimester genetic amniocentesis. Prenatal Diagnosis 26:925–930.
- Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. 2008. Revisiting the fetal loss rate after second-trimester genetic amniocentesis. Obstetrics and Gynecology 111:589–595.
- Papantoniou NE, Daskalakis GJ, Tziotis JG, Kitmirides SJ, Mesogitis SA, Antsaklis AJ. 2001. Risk factors predisposing to fetal loss following a second trimester amniocentesis. British Journal of Obstetrics and Gynaecology 108:1053–1056.
- Porreco RP, Young PE, Resnik R, Cousins L, Jones OW, Richards T . 1982. Reproductive outcome following amniocentesis for genetic indications. American Journal of Obstetrics and Gynecology 143:653–660.
- Roper EC, Konije JC, De Chazal RC, Puckett DP, Oppenheimer CA, Taylor DJ. 1999. Genetic amniocentesis: gestation specific pregnancy outcome and comparison of outcome following early and traditional amniocentesis. Prenatal Diagnosis 19:803–807.
- Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. 1986. Randomized control trial of genetic amniocentesis in 4606 low-risk women. Lancet i:1287–1293.
- Towner D, Currier RJ, Lorey FW, Cunningham GC, Greve LC. 2007. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening. American Journal of Obstetrics and Gynecology 608:e1–e5.